Singapore markets close in 1 hour 53 minutes

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.76+1.94 (+22.00%)
At close: 04:00PM EST
10.71 -0.05 (-0.46%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close8.82
Open8.63
Bid0.00 x 1000
Ask0.00 x 900
Day's range8.62 - 10.78
52-week range5.41 - 29.90
Volume6,201,628
Avg. volume1,828,368
Market cap988.275M
Beta (5Y monthly)3.62
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Shares of Seres Therapeutics Rose More Than 21% on Tuesday

    Shares of Seres Therapeutics (NASDAQ: MCRB) climbed more than 21% on Tuesday. The biotech stock, which closed at $8.82 on Monday, opened at $8.63 on Tuesday, then took off, climbing to a daily high of $10.78 in the afternoon. The move was in direct contrast to the general market trend with both the Dow Jones Industrial Average and S&P 500 index down for the day.

  • Motley Fool

    Why Shares of Seres Therapeutics Are Up More Than 22% Wednesday

    The company's revenue was $126.7 million, compared with only $1.4 million year over year, with most of the increase from collaboration revenue from Seres' co-commercialization license agreement with Nestlé Health Science. The improved financial numbers were only part of the story. On Wednesday, Seres said it had established a collaboration with Swiss pharmaceutical company Bacthera to manufacture SER-109, Seres' lead therapy to treat recurrent Clostridioides difficle infection (rCDI).

  • Zacks

    Seres Therapeutics (MCRB) Q3 Earnings and Revenues Beat Estimates

    Seres Therapeutics (MCRB) delivered earnings and revenue surprises of 253.19% and 1681.10%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?